EVERSANA's Vikram Anand explains how disconnected PV systems and manual safety processes can create commercial delays after ...

Ten PBMs will integrate TrumpRx cash pricing into RTBT displays, allowing prescribers and patients to compare cash-pay versus plan benefit costs at the point of prescribing. Clinician workflow remains ...

Shawn Seamans, Chief Commercial Officer, CoverMyMeds | Authors | Pharmaceutical Commerce connects biopharma executives to insights on business processes, technologies, and strategies for taking ...

In this week's Pharma Pulse, Trump nominates Heidi Overton to lead the FDA, EVERSANA expands its AI-powered commercialization ...

Cardinal Health's Michelle Britt discusses the operating costs, cash flow strain and reimbursement pressures facing ...

Trump is expected to pick White House aide Dr. Heidi Overton to lead the FDA, pending Senate confirmation, as the agency ...

TrumpRx was launched as a White House most-favored-nation pricing vehicle, initially listing cash-pay discounts from five manufacturers and expanding participating products and companies over time.

Anamika Krishanpal, PhD, is a life sciences digital leader with over 15 years of experience operating at the intersection of biological domain science and digital engineering.

AI in PV can compress the interval between signal observation and documented action, preserving benefit–risk integrity and ...

Government participation via TrumpRx has amplified price-transparency expectations, while 17 MFN deals and added generics increase visibility into manufacturer access pathways. February OIG guidance ...

Four pharma experts discuss industry trends in M&A, direct-to-patient sales, patient access and commercial strategy at the H1 midyear mark. Access our complete H1/H2 industry report: Six Months In: A ...

In this week's Pharma Pulse, a senior source denies AstraZeneca and Bristol Myers Squibb are in merger talks, Cleveland Clinic and Arrive AI push drone delivery toward pharma's last mile, Kenco's AI ...